BioSpace News Archive

CEL-SCI Corporation announced that the Independent Data Monitoring Committee for the Company’s pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* has completed its recent review of the Phase 3 study data.

Mr. Dickinson joined Gilead in 2016 and has transformed the way that the company approaches corporate development, expanding the kinds of transactions executed and implementing a broader and more strategic approach to deal-making.

The poster presentations will highlight preclinical data from three of Aptinyx’s clinical-stage product candidates that are in development for chronic pain, PTSD, and cognitive impairment.

The company recently launched an inter-connected platform with select partners that represent the cutting-edge of wound care devices.

He is now a board member of the combined Clockspring-NRI corporation.

The audios offer solutions to multiple problems such as sleeplessness, stress-related issues or general malaise and help users overcome these difficulties to enjoy happier, more fulfilling lives.

About 66% of women blame themselves for losing a pregnancy, and almost half were advised erroneously by doctor to wait a few cycles before trying to conceive again

NetDiligence®, a leading provider of cyber risk readiness and response services, today announced that significant enhancements to its innovative Breach Plan Connect® (BPC) software are being released early next year.

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, today announced the addition of Scott Applebaum to its team as lead strategic regulatory consultant.

Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the development of genetic and molecular diagnostics and companion therapeutics, announces that it has engaged CLSA Capital Markets Limited, a CITIC Securities Company, to provide introductions to potential strategic partners and regulatory guidance to support the launch of its proprietary genetic-based products into China’s (PRC) rapidly growing markets for women’s health and fertility.